Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Buy
80
TGTX Quote, Financials, Valuation and Earnings
Last price:
$40.30
Seasonality move
:
13.94%
Day range:
$38.75 - $40.70
52-week range:
$12.93 - $41.85
Dividend yield:
0%
P/E ratio:
284.86x
P/S ratio:
18.99x
P/B ratio:
28.17x
Volume:
1.8M
Avg. volume:
2.8M
1-year change:
164.98%
Market cap:
$6.3B
Revenue:
$329M
EPS (TTM):
$0.14
TGTX Analysts' Consensus Rating
The 5 analysts providing 12-month price projections for TG Therapeutics shares anticipate an average target of $42.83, ranging from a low estimate of $10.00 to a high estimate of $55.00. This average target implies a growth of 7.41% compared to the current stock price of $39.88.
Consensus Price Target
$42.83
Highest Price Target
$55.00
Lowest Price Target
$10.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 5 | 5 | 5 |
| Hold | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
TGTX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 9.21% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.56% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 0.6% over the past day.
